Clinical Efficacy or Tildrakizumab in Patients with Chronic Plaque Psoriasis Over 2 Years of Treatment: Results from Long-Term Extensions to 2 Phase 3 Clinical Studies

Kim Papp, Kristian Reich, Andrew Blauvelt, Diamant Thaci, Rodney Sinclair, Stephen K Tyring, Nicole Cichanowitz, Stuart Green, Qing Li, Carmen La Rosa

Abstract


Abstract not available.

 

Study supported by Merck & Co., Inc.


Keywords


psoriasis; tildrakizumab; clinical trial

Full Text: Poster PDF

DOI: 10.25251/skin.2.supp.4

Abstract - 147 Poster PDF - 43

Refbacks

  • There are currently no refbacks.

ISSN: 2574-1624

x
Message